Delivery Order SPE2DB24D8003-SPE2DB25FJTFC
Award Date
10/30/24
Potential Completion Date
10/31/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. The total ceiling value of the contract is $2,777.10, with a period of performance through March 18, 2025. This contract is not set-aside and is a firm fixed-price delivery order. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract...
The Defense Logistics Agency (DLA) awarded a $1,184.36 firm fixed-price delivery order contract to Dakota Drug, Inc., a small disadvantaged business. The contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a prescription medication. This delivery order falls under Dakota Drug, Inc.'s $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4,563,570 units of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price of $2,849.87 and a completion date of February 7, 2024. The contract is not a set-aside and is an unrestricted award. Dakota Drug, Inc. is an experienced federal contractor,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DX15D8002, is for the delivery of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has a ceiling value of $2,704.11 and a period of performance through November 1, 2023. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a range of pharmaceutical and medical products...
This is a $2,157.72 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, with a period of performance ending on November 25, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT Generation V Program. This...
This is a $1,979.66 firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is for the delivery of 4562235206 VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC is part of the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4562920866 VYVANSE 20 MG CAPSULE 100S. The contract award ID is SPE2DX15D8002|SPE2DX24F2TX1, with a ceiling value of $1,380.43. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 29, 2023. This award is not associated with a set-aside program. Dakota Drug, Inc. holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,201.92, is for the delivery of 100 units of the prescription medication Vyvanse 30 mg capsules. It is a firm fixed-price delivery order contract with a completion date of March 5, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., identified as SPE2DB24D8001 and valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Vyvanse 10mg capsules, a prescription medication, with a ceiling value of $2,511.86 and a period of performance through February 19, 2025. The contract is not set aside and is a Firm Fixed Price type. Dakota Drug, Inc. is the prime contractor and no subcontractors are mentioned. This contract is likely part of the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,220.61, is for the delivery of 4567200933 VYVANSE 10 MG CAPSULE 100S. The contract has an ultimate completion date of February 10, 2025. Dakota Drug, Inc. is the prime contractor and there are no major subcontractors mentioned. This appears to be a standalone delivery order and not part of a larger contract...